Before taking Vocabria(Cabotegravir)
Key precautions include HIV screening, monitoring for hypersensitivity, liver toxicity, and depression.
Warnings and Precautions
Important precautions involve confirming HIV-1 negative status before PrEP initiation and regular testing during use. Hypersensitivity reactions, including severe skin conditions, necessitate immediate discontinuation. Hepatotoxicity has been reported, recommending liver function monitoring. Depressive disorders, such as mood changes or suicidal thoughts, should be evaluated promptly. Avoid concomitant use with strong UGT1A1 inducers like rifampin or anticonvulsants. Adherence to dosing is vital to reduce resistance risk.
